MOONLAKE IMMUNOTHERAPEUTICS Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MOONLAKE IMMUNOTHERAPEUTICS stock issued during period, shares, new issues for the quarter ending 2024-03-31 was 914.83K shares.
- MOONLAKE IMMUNOTHERAPEUTICS stock issued during period, shares, new issues for the quarter ending 2023-06-30 was 9.74M shares.
- MOONLAKE IMMUNOTHERAPEUTICS stock issued during period, shares, new issues for fiscal 2024 was 914.83K shares, a 91.09% decline from fiscal 2023.
- MOONLAKE IMMUNOTHERAPEUTICS stock issued during period, shares, new issues for fiscal 2023 was 10.27M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2024-12-31 | 914.83K shares 10-K · filed 2025-02-26 | |
| 2024-03-31 | 914.83K shares 10-Q · filed 2024-11-07 | |
| 2023-12-31 | 10.27M shares 10-K · filed 2025-02-26 | |
| 2023-06-30 | 9.74M shares 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |